Nicorette 4 mg nicotine gum

Nicorette is a globally recognized brand for nicotine replacement therapy (NRT), originally developed in the late 1970s in Helsingborg, Sweden, by the pharmaceutical company AB Leo. It was the first product of its kind on the market, pioneered by researcher Ove Fernö who sought a controlled way to deliver nicotine to help smokers quit.

Today, the brand's ownership is split by region. Outside of the United States, Nicorette is owned by Kenvue Inc., the consumer health spin-off from Johnson & Johnson established in 2022. In the US market, the brand is owned and marketed by Haleon (formerly the consumer healthcare division of GSK). This specific packaging, featuring Norwegian text ("medisinsk tyggegummi", "nøytral"), is distributed in Scandinavia through Kenvue's regional subsidiaries like JNTL Consumer Health. Manufacturing continues to have a strong footprint in Sweden at the original Helsingborg site, though production is supported by global pharmaceutical networks to meet worldwide demand.